Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corvus Pharmaceuticals (CRVS) Treasury Shares: 2023

Historic Treasury Shares for Corvus Pharmaceuticals (CRVS) over the last 1 years, with Dec 2023 value amounting to $400,000.

  • Corvus Pharmaceuticals' Treasury Shares was N/A to $400,000 in Q3 2024 from the same period last year, while for Sep 2024 it was $400,000, marking a year-over-year change of. This contributed to the annual value of $400,000 for FY2023, which is N/A change from last year.
  • Latest data reveals that Corvus Pharmaceuticals reported Treasury Shares of $400,000 as of FY2023.
  • Over the past 5 years, Corvus Pharmaceuticals' Treasury Shares peaked at $400,000 during FY2023, and registered a low of $400,000 during FY2023.
  • In the last 1 years, Corvus Pharmaceuticals' Treasury Shares had a median value of $400,000 in 2023 and averaged $400,000.